Edesa Biotech, Inc. (EDSA)
4.89
+0.13
(+2.73%)
USD |
NASDAQ |
Sep 03, 14:15
Edesa Biotech Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.01 |
| June 30, 2024 | 0.0135 |
| March 31, 2024 | 0.0134 |
| December 31, 2023 | 0.0134 |
| September 30, 2023 | 0.0134 |
| June 30, 2023 | 0.0146 |
| March 31, 2023 | 0.0144 |
| December 31, 2022 | 0.0143 |
| September 30, 2022 | 0.002 |
| June 30, 2022 | 0.0034 |
| March 31, 2022 | 0.0036 |
| December 31, 2021 | 0.0076 |
| September 30, 2021 | 0.0076 |
| June 30, 2021 | 0.0077 |
| March 31, 2021 | 0.0072 |
| December 31, 2020 | 0.0167 |
| September 30, 2020 | 0.018 |
| June 30, 2020 | 0.0227 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0267 |
| December 31, 2019 | 0.0515 |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ProMIS Neurosciences, Inc. | 0.00 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.72M |
| Total Liabilities (Quarterly) | 3.91M |
| Shareholders Equity (Quarterly) | 8.811M |
| Current Ratio | 2.757 |